AARON JONES: Open Payments
NPI 1700555398 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,629 in 157 payments from 14 companies in 2025. Trend: 2023 $1,211 · 2024 $2,084 · 2025 $15,629
Speaker / faculty: $12,100Food & beverage: $2,790Travel & lodging: $659Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 27 | $13,292 |
| Teva Pharmaceuticals USA, Inc. | 18 | $424 |
| Alkermes, Inc. | 19 | $408 |
| Neurocrine BioSciences, Inc. | 17 | $319 |
| Supernus Pharmaceuticals, Inc. | 34 | $292 |
| E.R. Squibb & Sons, L.L.C. | 11 | $224 |
| Otsuka America Pharmaceutical, Inc. | 10 | $207 |
| Vanda Pharmaceuticals Inc. | 9 | $186 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $147 |
| Tris Pharma Inc | 3 | $54 |
Products named: INVEGA SUSTENNA, ARISTADA, INGREZZA, Qelbree, COBENFY, UZEDY, AUSTEDO XR, CAPLYTA.
Industry payments across TN — which companies pay providers there.
